John Maraganore News
Most Popular John Maraganore Story
Alnylam trial shows RNAi works in humans
Alnylam is offering up the first signs that RNAi therapy may work in humans. In a small Phase II trial, Alnylam's Read more...
Latest Headlines
- November 13, 2009
- September 15, 2008
- February 29, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
